Go Symbol Lookup
Loading...

Stryker to Buy Boston Scientific Division

 Text Size  
Published: Thursday, 28 Oct 2010 | 8:52 AM ET
By: Associated Press

Stryker Corporation says it will pay up to $1.5 billion to buy the neurovascular division of fellow medical device maker Boston Scientific.

CNBC.com

The Kalamazoo, Mich., company plans to pay $1.4 billion at the deal's closing and then up to $100 million in milestone payments. The deal is expected to close in the fourth quarter.

Boston Scientific's neurovascular division had $348 million in sales last year. It makes detachable coils, stents and other devices used to treat brain aneurysms and other types of cerebrovascular disease. The company is based in Natick, Mass.

Boston Scientific Neurovascular President Mark Paul will head the Stryker Neurovascular business.

 Print
Stryker Corporation says it will pay up to $1.5 billion to buy the neurovascular division of fellow medical device maker Boston Scientific.
  Price   Change %Change
BSX ---
SYK ---

   
Comments

 

More Comments

 
 

Add Comments

 

Your Comments (Up to 1100 characters):

Remaining characters

Your comments have not been posted yet.

Please review your submission to make sure you are comfortable with your entry.

Your Comments:


                
            
            
        

Private Equity

  • Nick Tolchard, head of Invesco Middle East tells CNBC they have seen more money flowing into private equity investment.

  • *Money managers pull $1.4 bln from COMEX gold in May 14 week. Money managers, including hedge funds, pulled $1.4 billion from the U.S. gold futures market for the week ended May 14 by trimming their net long positions in the metal, according to Reuters calculations of data released by the Commodity Futures Trading Commission.

  • *Money managers pull $1.4 bln from COMEX gold in May 14 week. Money managers, including hedge funds, pulled $1.4 billion from the U.S. gold futures market for the week ended May 14 by trimming their net long positions in the metal, according to Reuters calculations of data released by the Commodity Futures Trading Commission.